A new synaptic player leading to autism risk: Met receptor tyrosine kinase

Journal of Neurodevelopmental Disorders

Volumn 3, Issue 3, 2011, Pages 282-292

  Judson, Matthew C ^a   Eagleson, Kathie L ^b   Levitt, Pat ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Autism spectrum disorder; Forebrain; Hepatocyte growth factor; Human genetics; Synaptogenesis

Indexed keywords

EID: 85027938891     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1007/s11689-011-9081-8     Document Type: Review

References (101)

1. Akimoto M, Baba A, Ikeda-Matsuo Y, Yamada MK, Itamura R, Nishiyama N, et al. Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience. 2004; 128(1): 155-62.
2. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet. 2008; 82(1): 150-9.
3. Alexander AL, Lee JE, Lazar M, Boudos R, DuBray MB, Oakes TR, et al. Diffusion tensor imaging of the corpus callosum in Autism. Neuroimage. 2007; 34(1): 61-73.
4. Anderson JS, Druzgal TJ, Froehlich A, Dubray MB, Lange N, Alexander AL, et al. Decreased Interhemispheric Functional Connectivity in Autism. Cereb Cortex. 2010 Oct 12.
5. Bakkaloglu B, O'Roak BJ, Louvi A, Gupta AR, Abelson JF, Morgan TM, et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet. 2008; 82(1): 165-73.
6. Batshaw ML. Children with disabilities. 5th ed. Batshaw ML, editor. Baltimore: Brookes; 2002.
7. Bill BR, Geschwind DH. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev. 2009; 19(3): 271-8.
8. Bourgeois J. Synaptogenesis, heterochrony and epigenesis in the mammalian neocortex. Acta Paediatr Suppl. 1997; 422: 27-33.
9. Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol. 2009; 19(2): 231-4.
10. Buie T, Campbell DB, Fuchs 3rd GJ, Furuta GT, Levy J, Vandewater J, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010; 125 Suppl 1: S1-18.
11. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005; 42(4): 318-21.
12. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA. 2006; 103(45): 16834-9.
13. Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol. 2007; 62(3): 243-50.
14. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res. 2008; 1(3): 159-68.
15. Campbell DB, Buie TM, Winter H, Bauman M, Sutcliffe JS, Perrin JM, et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics. 2009a; 123(3): 1018-24.
16. Campbell DB, Warren D, Sutcliffe JS, Lee EB, Levitt P. Association of MET with social and communication phenotypes in individuals with autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 22.
17. Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in autism. Neurology. 2002; 58(3): 428-32.
18. Casanova MF, El-Baz A, Vanbogaert E, Narahari P, Switala A. A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol. 2010; 20(2): 451-8.
19. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proceedings of the National Academy of Sciences of the United States of America. 1997 May 13; 94(10): 5401-4.
20. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 1984 Sep 6-11; 311(5981): 29-33.
21. Courchesne E, Pierce K. Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr Opin Neurobiol. 2005; 15(2): 225-30.
22. Crawley JN. Behavioral phenotyping strategies for mutant mice. Neuron. 2008; 57(6): 809-18.
23. David MD, Yeramian A, Duñach M, Llovera M, Cantí C, de Herreros AG, et al. Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential beta-catenin phosphorylation. J Cell Sci. 2008; 121(Pt 16): 2718-30.
24. Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Human Molecular Genetics. 2007 Sep 27; 17(1): 111-8.
25. Eagleson KL, Campbell DB, Thompson BL, Bergman MY, Levitt P. The autism risk genes MET and PLAUR differentially impact cortical development. Autism Research. 2010; 3: 1-16.
26. Ebens A, Brose K, Leonardo ED, Hanson MG, Bladt F, Birchmeier C, et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron. 1996; 17(6): 1157-72.
27. Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1977; 18(4): 297-321.
28. Fukuda T, Itoh M, Ichikawa T, Washiyama K, Goto Y-i. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol. 2005 Jun 1; 64(6): 537-44.
29. Galvez R, Greenough WT. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am J Med Genet. 2005 Jun 1; 135A(2): 155-60.
30. Geschwind DH. Advances in autism. Annu Rev Med. 2009; 60: 367-80.
31. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol. 2007; 17(1): 103-11.
32. Gibson JR, Huber KM, Sudhof TC. Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons. J Neurosci. 2009; 29(44): 13883-97.
33. Gutierrez H, Dolcet X, Tolcos M, Davies A. HGF regulates the development of cortical pyramidal dendrites. Development. 2004; 131(15): 3717-26.
34. Hung AY, Futai K, Sala C, Valtschanoff JG, Ryu J, Woodworth MA, et al. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci. 2008; 28(7): 1697-708.
35. Irwin SA, Idupulapati M, Gilbert ME, Harris JB, Chakravarti AB, Rogers EJ, et al. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet. 2002 Jul 29; 111(2): 140-6.
36. Ibrahim SH, Voigt RG, Katusic SK, Weaver AL, Barbaresi WJ. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics. 2009; 124(2): 680-6.
37. Jackson PB, Boccuto L, Skinner C, Collins JS, Neri G, Gurrieri F, et al. Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res. 2009; 2(4): 232-6.
38. Jentarra GM, Olfers SL, Rice SG, Srivastava N, Homanics GE, Blue M, et al. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. 2010 Mar 9: 1-15.
39. Johnson MB, Kawasawa YI, Mason CE, Krsnik Ž, Coppola G, Bogdanović D, et al. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron. 2009; 62(4): 494-509.
40. Judson MC, Bergman MY, Campbell DB, Eagleson KL, Levitt P. Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol. 2009; 513(5): 511-31.
41. Judson M, Eagleson K, Wang L, Levitt P. Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain. J Comp Neurol. 2010; 518: 4463-78.
42. Judson MC, Amaral DG, Levitt P. Conserved Subcortical and Divergent Cortical Expression of Proteins Encoded by Orthologs of the Autism Risk Gene MET. Cerebral Cortex. 2011 Dec 1; in press.
43. Just MA, Cherkassky VL, Keller TA, Minshew NJ. Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain. 2004; 127(Pt 8): 1811-21.
44. Just MA, Cherkassky VL, Keller TA, Kana RK, Minshew NJ. Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cereb Cortex. 2007; 17(4): 951-61.
45. Kana RK, Keller TA, Cherkassky VL, Minshew NJ, Just MA. Atypical frontal-posterior synchronization of Theory of Mind regions in autism during mental state attribution. Soc Neurosci. 2009; 4(2): 135-52.
46. Kermorgant S, Walker F, Hormi K, Dessirier V, Lewin MJ, Lehy T. Developmental expression and functionality of hepatocyte growth factor and c-Met in human fetal digestive tissues. Gastroenterology. 1997; 112(5): 1635-47.
47. Kishi N, Macklis JD. MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Exp Neurol. 2010 Feb 11; 222(1): 51-8.
48. Kitamura S, Kondo S, Shinomura Y, Isozaki K, Kanayama S, Higashimoto Y, et al. Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm Res. 2000; 49(7): 320-4.
49. Koshino H, Kana RK, Keller TA, Cherkassky VL, Minshew NJ, Just MA. fMRI investigation of working memory for faces in autism: visual coding and underconnectivity with frontal areas. Cereb Cortex. 2008; 18(2): 289-300.
50. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, et al. Pten regulates neuronal arborization and social interaction in mice. Neuron. 2006; 50(3): 377-88.
51. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP, et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet. 2004; 74(3): 552-7.
52. Lee Y-S, Silva AJ. The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci. 2009; 10(2): 126-40.
53. Levitt P, Campbell DB. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest. 2009; 119(4): 747-54.
54. Levitt P, Eagleson KL, Powell EM. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci. 2004; 27(7): 400-6.
55. Lim CS, Walikonis RS. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cell Signal. 2008; 20(5): 825-35.
56. Lim S, Naisbitt S, Yoon J, Hwang JI, Suh PG, Sheng M, et al. Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J Biol Chem. 1999; 274(41): 29510-8.
57. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008; 82(2): 477-88.
58. Matsubara Y, Ichinose M, Yahagi N, Tsukada S, Oka M, Miki K, et al. Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract. Biochem Biophys Res Commun. 1998; 253(2): 477-84.
59. Matsuzaki M, Ellis-Davies GC, Nemoto T, Miyashita Y, Iino M, Kasai H. Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons. Nat Neurosci. 2001; 4(11): 1086-92.
60. Meyer KD, Morris JA. Disc1 regulates granule cell migration in the developing hippocampus. Hum Mol Genet. 2009; 18(17): 3286-97.
61. Minshew NJ, Goldstein G, Siegel DJ. Neuropsychologic functioning in autism: profile of a complex information processing disorder. J Int Neuropsychol Soc. 1997; 3(4): 303-16.
62. Moeller S, Freiwald WA, Tsao DY. Patches with links: a unified system for processing faces in the macaque temporal lobe. Science. 2008; 320(5881): 1355-9.
63. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010; 13(10): 1161-9.
64. Nimchinsky EA, Oberlander AM, Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci. 2001 Jul 15; 21(14): 5139-46.
65. Otal R, Martinez A, Soriano E. Lack of TrkB and TrkC signaling alters the synaptogenesis and maturation of mossy fiber terminals in the hippocampus. Cell Tissue Res. 2005; 319(3): 349-58.
66. Pierce K, Redcay E. Fusiform function in children with an autism spectrum disorder is a matter of "who". Biol Psychiatry. 2008; 64(7): 552-60.
67. Pinsk MA, DeSimone K, Moore T, Gross CG, Kastner S. Representations of faces and body parts in macaque temporal cortex: a functional MRI study. Proc Natl Acad Sci USA. 2005; 102(19): 6996-7001.
68. Pinsk MA, Arcaro M, Weiner KS, Kalkus JF, Inati SJ, Gross CG, et al. Neural representations of faces and body parts in macaque and human cortex: a comparative fMRI study. J Neurophysiol. 2009; 101(5): 2581-600.
69. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010; 466(7304): 368-72.
70. Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 1994; 77(2): 261-71.
71. Powell EM, Mars WM, Levitt P. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron. 2001; 30(1): 79-89.
72. Powell EM, Mühfriedele S, Bolz JUR, Levitt P. Differential regulation of thalamic and cortical axonal growth by hepatocyte growth factor/scatter factor. Dev Neurosci. 2003; 25(2-4): 197-206.
73. Qiu S, Anderson CT, Levitt P, Shepherd GMG. Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase. J Neurosci. 2011; 31: 5855-64.
74. Reber M. Dual diagnosis: mental retardation and psychiatric disorders. 5th ed. Batshaw ML, editor. Baltimore: Brookes; 2002.
75. Risch N. Implications of multilocus inheritance for gene-disease association studies. Theor Popul Biol. 2001; 60(3): 215-20.
76. Ronald A, Happe F, Bolton P, Butcher LM, Price TS, Wheelwright S, et al. Genetic heterogeneity between the three components of the autism spectrum: a twin study. J Am Acad Child Adolesc Psychiatry. 2006a; 45(6): 691-9.
77. Ronald A, Happe F, Price TS, Baron-Cohen S, Plomin R. Phenotypic and genetic overlap between autistic traits at the extremes of the general population. J Am Acad Child Adolesc Psychiatry. 2006b; 45(10): 1206-14.
78. Rubenstein JL. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol. 2010; 23(2): 118-23.
79. Rubenstein JLR, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003; 2(5): 255-67.
80. Ryan TJ, Grant SGN. The origin and evolution of synapses. Nat Rev Neurosci. 2009; 10(10): 701-12.
81. Sahyoun CP, Belliveau JW, Soulieres I, Schwartz S, Mody M. Neuroimaging of the functional and structural networks underlying visuospatial vs. linguistic reasoning in high-functioning autism. Neuropsychologia. 2010; 48(1): 86-95.
82. Sato M, Stryker MP. Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proceedings of the National Academy of Sciences. 2010 Mar 23; 107(12): 5611-6.
83. Scott-van Zeeland AA, Abrahams BS, Alvarez-Retuerto AI, Sonnenblick LI, Rudie JD, Ghahremani D, et al. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med. 2010 Nov 3; 2(56): 56ra80.
84. Shukla DK, Keehn B, Muller RA. Tract-specific analyses of diffusion tensor imaging show widespread white matter compromise in autism spectrum disorder. J Child Psychol Psychiatry. 2010; 52(3): 286-95.
85. Shukla DK, Keehn B, Smylie DM, Muller RA. Microstructural abnormalities of short-distance white matter fiber tracts in autism spectrum disorder. Neuropsychologia. 2011 Feb 17.
86. Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, Holt R, et al. MET and autism susceptibility: family and case-control studies. Eur J Hum Genet. 2009; 17(6): 749-58.
87. Stefan M, Koch A, Mancini A, Mohr A, Weidner KM, Niemann H, et al. Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis. J Biol Chem. 2001; 276(5): 3017-23.
88. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry. 1989; 30(3): 405-16.
89. Sundaram SK, Kumar A, Makki MI, Behen ME, Chugani HT, Chugani DC. Diffusion tensor imaging of frontal lobe in autism spectrum disorder. Cereb Cortex. 2008; 18(11): 2659-65.
90. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science. 2007; 318(5847): 71-6.
91. Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, et al. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther. 2003; 307(1): 146-51.
92. Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005 Dec 6; 8(12): 1727-34.
93. Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, et al. Further evidence for the role of MET in autism susceptibility. Neurosci Res. 2010; 68(2): 137-41.
94. Thomas C, Humphreys K, Jung KJ, Minshew N, Behrmann M. The anatomy of the callosal and visual-association pathways in high-functioning autism: A DTI tractography study. Cortex. 2010 Aug 3.
95. Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol. 2010; 11(12): 834-48.
96. Tsao DY, Livingstone M. Mechanisms of face perception. Ann Rev Neurosci. 2008; 31: 411-37.
97. Tyndall SJ, Walikonis RS. The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle. 2006; 5(14): 1560-8.
98. Tyndall SJ, Walikonis RS. Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activity. Synapse. 2007; 61(4): 199-204.
99. Tyndall SJ, Patel SJ, Walikonis RS. Hepatocyte growth factor-induced enhancement of dendritic branching is blocked by inhibitors of N-methyl-d-aspartate receptors and calcium/calmodulin-dependent kinases. J Neurosci Res. 2007; 85(11): 2343-51.
100. Varoqueaux F, Aramuni G, Rawson RL, Mohrmann R, Missler M, Gottmann K, et al. Neuroligins determine synapse maturation and function. Neuron. 2006; 51(6): 741-54.
101. Yashiro K, Riday T, Condon K, Roberts A. Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci. 2009 Jan 1.